Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them. OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added years of improved quality of life.
Location: United Kingdom, England, London
Employees: 1-10
Total raised: $1.5M
Founded date: 2021
Investors 5
| Date | Name | Website |
| - | Science An... | scienceang... |
| 28.03.2023 | Startup Fu... | sfccapital... |
| - | Empirical ... | empiricalv... |
| - | Syndicate ... | syndicater... |
| - | Parkwalk A... | parkwalkad... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.03.2023 | Seed | $1.5M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 05.04.2023 | Oxford Innovation invest in 3D printed biomimetic implants s... | Oxford Innovation EIS Growth Fund alongside OION angel investors, have invested in the £1.2 million ... | oion.co.uk... |
| 30.03.2023 | Imperial startup OSSTEC has raised £1.2 million to take its ... | - | scienceang... |
| - | OSSTEC | “Home” | fastfounde... |